Thyroid Eye Disease
📧 Sign up to get email alerts when something new happens for Thyroid Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) [Phase 2, Phase 3]
Phase 2b/Phase 3 clinical trial results for linsitinib in active moderate to severe thyroid eye disease (Graves orbitopathy).
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial update for VRDN-003 in active thyroid eye disease (TED) focusing on efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Results: An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301 [Phase 3]
Phase 3 open-label study results for non-responders to VRDN-001-101 and VRDN-001-301 in Thyroid Eye Disease have been completed with results…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial results for VRDN-001 in thyroid eye disease have been completed with safety and tolerability reported.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial results for Veligrotug (VRDN 001) in thyroid eye disease have been completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial results for Veligrotug (VRDN-001) in chronic thyroid eye disease evaluated efficacy, safety, and tolerability; study completed…
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
Phase 3 trial evaluating satralizumab for efficacy and safety in thyroid eye disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
Phase 3 trial update for satralizumab in thyroid eye disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
Phase 3 trial evaluating satralizumab for thyroid eye disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
A Phase 3 trial evaluating satralizumab for thyroid eye disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Update: A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) [Phase 3]
Phase 3 clinical trial update reporting safety, tolerability, and pharmacokinetics of VRDN-003 in participants with Thyroid Eye Disease; stu…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease [Phase 1, Phase 2]
AMG 732 is being studied in healthy participants and individuals with Thyroid Eye Disease in Phase 1/2 trials, and the study is currently re…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease [Phase 3]
A Phase 3 trial evaluating batoclimab for active Thyroid Eye Disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Evaluation of K9 in Subjects With Thyroid Eye Disease (TED) [Phase 1]
The Phase 1 trial evaluating K9 in subjects with Thyroid Eye Disease has been terminated. No phase 1 results are reported in this update.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease [Phase 3]
A Phase 3 study of subcutaneously administered efgartigimod for Thyroid Eye Disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease [NA]
A completed clinical trial evaluating Triamcinolone Acetonide Injection for upper eyelid retraction in Thyroid Eye Disease. The study was sp…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease. [Phase 3]
A Phase 3 trial evaluating subcutaneous efgartigimod (PH20 SC) for adults with Thyroid Eye Disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) [Phase 1, Phase 2]
This document notes a Phase 1/2 clinical trial evaluating NTB003 for thyroid eye disease, which is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease [Phase 2]
A Phase 2 study evaluating the efficacy and safety of LASN01 in Thyroid Eye Disease (Graves' ophthalmopathy) has completed and results are p…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Psychological Burden of Thyroid Eye Disease
This entry reports the completion of a clinical trial examining the psychological burden associated with Thyroid Eye Disease.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease [Phase 3]
An extension-phase 3 study of batoclimab for Thyroid Eye Disease is listed as active but not recruiting. This document serves as a status up…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) [Phase 3]
A randomized Phase 3 trial evaluating VRDN-001 for Thyroid Eye Disease has completed, including safety and tolerability assessments.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301 [Phase 3]
This document reports the completion of an open-label Phase 3 study for non-responders to VRDN-001-101 and VRDN-001-301 in Thyroid Eye Disea…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study of VV-14305 for the Treatment of Thyroid Eye Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for VV-14305 in Thyroid Eye Disease, sponsored by Kriya Therapeutics; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
A Phase 3 study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in patients with Thyroid Eye Disease…